The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Bibliografiset tiedot
Päätekijät:	Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	BMC 2025-01-01
Sarja:	BMC Complementary Medicine and Therapies
Aiheet:	Mild cognitive impairment Alzheimer’s disease Cannabidiol Cannabis-based medicine Patient engagement Patient and public involvement
Linkit:	https://doi.org/10.1186/s12906-025-04753-w

Samankaltaisia teoksia

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
Tekijä: Ana Pilar Pérez-Acevedo, et al.
Julkaistu: (2020-12-01)

Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study)
Tekijä: Elmar Graessel, et al.
Julkaistu: (2024-10-01)

3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
Tekijä: Anna Gościniak, et al.
Julkaistu: (2024-11-01)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
Tekijä: Zackary Montoya, et al.
Julkaistu: (2020-09-01)

El cannabidiol y sus indicaciones en psiquiatría
Tekijä: Juan Fernando Muñoz Ramírez
Julkaistu: (2021-03-01)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from <i>Cannabis sativa</i> (Henola Variety) Inflorescences
Tekijä: Anna Stasiłowicz-Krzemień, et al.
Julkaistu: (2023-09-01)

Predictors of institutionalization in users of day care facilities with mild cognitive impairment to moderate dementia
Tekijä: Klara Spiegl, et al.
Julkaistu: (2021-09-01)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
Tekijä: Kelsey Meyer, et al.
Julkaistu: (2022-01-01)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
Tekijä: Davide Fortin, et al.
Julkaistu: (2021-10-01)

Cannabidiol use and perceptions in France: a national survey
Tekijä: Clémence Casanova, et al.
Julkaistu: (2022-08-01)

Pharmacovigilance on cannabidiol as an antiepileptic agent
Tekijä: Ilaria Ammendolia, et al.
Julkaistu: (2023-02-01)

Patterns of cannabidiol use among marijuana users in the United States
Tekijä: Ji-Yeun Park
Julkaistu: (2025-02-01)

The Effects of Cannabidiol on the Driving Performance of Healthy Adults: A Pilot RCT
Tekijä: Toni Marie Rudisill, MS, PhD, et al.
Julkaistu: (2023-03-01)

Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
Tekijä: Milena de Barros Viana, et al.
Julkaistu: (2022-11-01)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
Tekijä: Masashi Kitamura, et al.
Julkaistu: (2020-09-01)

Effects of Cannabidiol on Locomotor Activity
Tekijä: Fabrizio Calapai, et al.
Julkaistu: (2022-04-01)

A Balanced Approach for Cannabidiol Use in Chronic Pain
Tekijä: Donovan A. Argueta, et al.
Julkaistu: (2020-04-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
Tekijä: Qianru Rao, et al.
Julkaistu: (2022-11-01)

Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions
Tekijä: Zuzanna Lubczyńska, et al.
Julkaistu: (2023-06-01)

In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract
Tekijä: Paweł Śledziński, et al.
Julkaistu: (2023-12-01)

Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs
Tekijä: Sasithorn Limsuwan, et al.
Julkaistu: (2024-04-01)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from <i>Cannabis sativa</i> L.
Tekijä: Laura Daniela Martinenghi, et al.
Julkaistu: (2020-06-01)

Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers
Tekijä: Marco Antonio Zenone, et al.
Julkaistu: (2021-07-01)

Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes
Tekijä: Schilling JM, et al.
Julkaistu: (2021-05-01)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
Tekijä: Francesco Paolo Busardò, et al.
Julkaistu: (2021-01-01)

Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey
Tekijä: Tangui Barré, et al.
Julkaistu: (2024-01-01)

Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
Tekijä: Diana E. Sepulveda, et al.
Julkaistu: (2022-10-01)

Total cannabidiol (CBD) concentrations and yields from traditional extraction methods: Percolation vs. maceration
Tekijä: Jason Wilson, et al.
Julkaistu: (2022-10-01)

Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists
Tekijä: Gniewko Wieckiewicz, et al.
Julkaistu: (2022-03-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
Tekijä: Swapnali Chetia, et al.
Julkaistu: (2020-08-01)

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
Tekijä: Zsolt Gáll, et al.
Julkaistu: (2020-05-01)

Cannabis Effects on Driving Performance: Clinical Considerations
Tekijä: Brianna Costales, et al.
Julkaistu: (2023-01-01)

Production of Cannabidiol Acid Synthase by Chassis Pichia pastoris and of Its Catalytic Activity Analysis
Tekijä: Tingli NIU, et al.
Julkaistu: (2023-10-01)

What are the informational pathways that shape people’s use of cannabidiol for medical purposes?
Tekijä: Marco A. Zenone, et al.
Julkaistu: (2021-05-01)

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
Tekijä: Anjali K. Bhardwaj, et al.
Julkaistu: (2024-03-01)

The Potential of Cannabidiol for Treating Canine Atopic Dermatitis
Tekijä: Ana F. Bizarro, et al.
Julkaistu: (2025-02-01)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
Tekijä: John S. Markowitz, et al.
Julkaistu: (2022-11-01)

Safety assessment of female sexual hygiene product containing cannabidiol in new zealand white rabbit and clinical trial
Tekijä: Atiwut Kamudhamas, et al.
Julkaistu: (2024-12-01)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Tekijä: José A. Crippa, et al.
Julkaistu: (2018-09-01)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
Tekijä: Luisa Rocha, et al.
Julkaistu: (2020-03-01)